These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38796188)

  • 1. Eltrombopag-cyclosporin A in treating severe aplastic anaemia - Authors' reply.
    Scheinberg P
    Lancet Haematol; 2024 Jun; 11(6):e398. PubMed ID: 38796188
    [No Abstract]   [Full Text] [Related]  

  • 2. Eltrombopag-cyclosporin A in treating severe aplastic anaemia.
    Sathiamoorthy KS; Manikandan S
    Lancet Haematol; 2024 Jun; 11(6):e397. PubMed ID: 38796186
    [No Abstract]   [Full Text] [Related]  

  • 3. [Eltrombopag combined with cyclosporine alone for treatment of very severe aplastic anemia: a case report].
    Cheng H; Wang X; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):612. PubMed ID: 32397030
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Filippidou M; Avgerinou G; Tsipou H; Tourkantoni N; Katsibardi K; Vlachou A; Roka K; Solomou E; Kattamis A
    Br J Haematol; 2020 Aug; 190(3):e157-e159. PubMed ID: 32529633
    [No Abstract]   [Full Text] [Related]  

  • 5. Eltrombopag combined with cyclosporine may have an effect on very severe aplastic anemia.
    Cheng H; Wang X; Zhou D; Cao J; Larochelle A; Xu KL
    Ann Hematol; 2019 Aug; 98(8):2009-2011. PubMed ID: 30891613
    [No Abstract]   [Full Text] [Related]  

  • 6. Consideration of ATG-free therapy with eltrombopag and cyclosporine for severe aplastic anaemia.
    Groarke EM
    Lancet Haematol; 2024 Mar; 11(3):e173-e174. PubMed ID: 38335977
    [No Abstract]   [Full Text] [Related]  

  • 7. Eltrombopag in refractory aplastic anemia.
    Akard L
    N Engl J Med; 2012 Sep; 367(12):1162-3; author reply 1163. PubMed ID: 22992085
    [No Abstract]   [Full Text] [Related]  

  • 8. Eltrombopag in refractory aplastic anemia.
    Oshima Y; Yuji K; Tojo A
    N Engl J Med; 2012 Sep; 367(12):1162; author reply 1163. PubMed ID: 22992084
    [No Abstract]   [Full Text] [Related]  

  • 9. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
    Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS
    N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare side effect: eltrombopag associated hyperpigmentation.
    Atay H; Kelkitli E; Turgut M
    G Ital Dermatol Venereol; 2020 Dec; 155(6):803-804. PubMed ID: 31104458
    [No Abstract]   [Full Text] [Related]  

  • 11. Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia.
    Gao Q; Zhang L; Zhao X; Zhu Y; Peng G; Li Y; Li Y; Li J; Song L; Ye L; Fan H; Zhou K; Yang W; Yang Y; Jing L; Zhang F
    Hematology; 2020 Dec; 25(1):341-347. PubMed ID: 32915111
    [No Abstract]   [Full Text] [Related]  

  • 12. The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia.
    Gill H; Leung GM; Lopes D; Kwong YL
    Br J Haematol; 2017 Mar; 176(6):991-994. PubMed ID: 27097929
    [No Abstract]   [Full Text] [Related]  

  • 13. Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
    Peffault de Latour R; Kulasekararaj A; Iacobelli S; Terwel SR; Cook R; Griffin M; Halkes CJM; Recher C; Barraco F; Forcade E; Vallejo JC; Drexler B; Mear JB; Smith AE; Angelucci E; Raymakers RAP; de Groot MR; Daguindau E; Nur E; Barcellini W; Russell NH; Terriou L; Iori AP; La Rocca U; Sureda A; Sánchez-Ortega I; Xicoy B; Jarque I; Cavenagh J; Sicre de Fontbrune F; Marotta S; Munir T; Tjon JML; Tavitian S; Praire A; Clement L; Rabian F; Marano L; Hill A; Palmisani E; Muus P; Cacace F; Frieri C; van Lint MT; Passweg JR; Marsh JCW; Socié G; Mufti GJ; Dufour C; Risitano AM;
    N Engl J Med; 2022 Jan; 386(1):11-23. PubMed ID: 34986284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eltrombopag mobilizes iron in patients with aplastic anemia.
    Zhao Z; Sun Q; Sokoll LJ; Streiff M; Cheng Z; Grasmeder S; Townsley DM; Young NS; Dunbar CE; Winkler T
    Blood; 2018 May; 131(21):2399-2402. PubMed ID: 29632023
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study.
    Scheinberg P; Finelli C; Montaňo-Figueroa EH; Vallejo C; Norasetthada L; Calado RT; Turgut M; Peffault de Latour R; Kriemler-Krahn U; Haenig J; Clark J; Jang J
    Lancet Haematol; 2024 Mar; 11(3):e206-e215. PubMed ID: 38335978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.
    Groarke EM; Patel BA; Gutierrez-Rodrigues F; Rios O; Lotter J; Baldoni D; St Pierre A; Shalhoub R; Wu CO; Townsley DM; Young NS
    Br J Haematol; 2021 Feb; 192(3):605-614. PubMed ID: 33410523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of eltrombopag in severe aplastic anemia.
    Scheinberg P
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):450-456. PubMed ID: 30504345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Eltrombopag for Aplastic Anemia: A Systematic Review and Meta-analysis.
    Hong Y; Li X; Wan B; Li N; Chen Y
    Clin Drug Investig; 2019 Feb; 39(2):141-156. PubMed ID: 30406906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag: a stem cell cookie?
    Marsh JC; Mufti GJ
    Blood; 2014 Mar; 123(12):1774-5. PubMed ID: 24652959
    [No Abstract]   [Full Text] [Related]  

  • 20. Upfront eltrombopag monotherapy induces stable hematologic remission in pediatric patients with nonsevere idiopathic aplastic anemia.
    Geng W; Kearney S; Nelson S
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27290. PubMed ID: 29932285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.